Companion Animal Diagnostics Market Size & Growth Forecast 2027–2036, By Segments (Application, Technology, Animal, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Companion Animal Diagnostics Market size was worth USD 7.8 billion in 2026 and is expected to grow at a 8.84% CAGR between 2027 and 2036, surpassing USD 18.2 billion by 2036. The industry revenue for 2027 is calculated at USD 8.38 billion.
Get more details on this report
Request Free Sample ReportCompanion Animal Diagnostics Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 40.18% share supported by mature veterinary infrastructure, high pet healthcare spending, and routine diagnostic integration across clinics and reference laboratories.
- Asia Pacific growth is driven by rising pet ownership, expanding veterinary clinics, and increasing demand for early disease detection and preventive testing, supporting 10.85% CAGR.
Segment Momentum
- Clinical Biochemistry captured 24.79% of the market in 2026 because it is routinely used for health assessments, organ function evaluation, and management of common chronic conditions in veterinary practice.
- Molecular Diagnostics is the fastest-growing technology segment as veterinary providers increasingly seek higher-specificity testing and more precise identification of infectious and complex conditions.
Market Expansion Drivers
- Rising pet ownership and increased spending on advanced veterinary diagnostic services.
- Technological advancements in point-of-care molecular diagnostics and AI imaging systems.
- Expansion of pet insurance and preventive wellness programs increasing diagnostic utilization frequency.
Leading Market Participants
- Leading companies in the companion animal diagnostics market include IDEXX Laboratories Inc. (United States), Zoetis Inc. (United States), Thermo Fisher Scientific Inc. (United States), Antech Diagnostics Inc. (United States), FUJIFILM Corporation (Japan), Virbac S.A. (France), bioMérieux SA (France), Neogen Corporation (United States), Embark Veterinary Inc. (United States), Esaote S.p.A. (Italy).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 7.8 billion
- 2027 Estimated Market Size: USD 8.38 billion.
- Projected Market Size: USD 18.2 billion by 2036
- Growth Forecast: 8.84% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Clinical Pathology (Application) | Clinical Biochemistry (Technology) | Dogs (Animal) | Diagnostic Laboratories (End Use)
- Emerging Opportunity Segment: Clinical Pathology (Application) | Molecular Diagnostics (Technology) | Cats (Animal) | Point-Of-Care/In-House Testing (End Use)
Market Growth Drivers and Industry Trends
Rising pet ownership and increased spending on advanced veterinary diagnostic services
Higher pet ownership and greater willingness to spend on veterinary care are expanding demand for advanced diagnostic services for companion animals. The companion animal diagnostics market is benefiting as pet owners place greater emphasis on identifying health conditions early and accessing comprehensive veterinary care. Increased expenditure on animal healthcare supports the use of diagnostic testing for disease detection, clinical assessment, and ongoing health management, creating broader demand for diagnostic capabilities across veterinary practices.
Technological advancements in point-of-care molecular diagnostics and AI imaging systems
Technological progress in point-of-care molecular diagnostics and AI-enabled imaging is improving the speed, accessibility, and analytical capabilities of veterinary testing. Such innovations are strengthening the companion animal diagnostics market by enabling veterinary professionals to obtain more actionable information closer to the point of care and evaluate diagnostic images with greater technological assistance. Faster testing and advanced image interpretation can support more efficient clinical decision-making while expanding the range of diagnostic procedures available within veterinary settings.
Expansion of pet insurance and preventive wellness programs increasing diagnostic utilization frequency
The expansion of pet insurance and preventive wellness programs is encouraging more consistent use of veterinary diagnostic services by reducing barriers to routine and medically necessary testing. Within the companion animal diagnostics market, broader coverage and structured wellness initiatives can promote regular health assessments rather than relying solely on diagnostics when animals become visibly ill. More frequent veterinary visits create additional opportunities for screening, monitoring, and early identification of potential health issues, increasing the utilization of diagnostic procedures.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising pet ownership and increased spending on advanced veterinary diagnostic services | 2.10% | Moderate | North America, Europe, Asia Pacific | High | Near Term |
| Technological advancements in point-of-care molecular diagnostics and AI imaging systems | 1.80% | Moderate | North America, Europe, Asia Pacific | High | Near Term |
| Expansion of pet insurance and preventive wellness programs increasing diagnostic utilization frequency | 1.40% | Moderate | North America, Europe | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America accounted for a 40.18% share of the companion animal diagnostics market in 2026, supported by high pet ownership, increasing expenditure on veterinary care, and widespread adoption of advanced diagnostic procedures. Veterinary practices are increasingly incorporating diagnostic testing into routine examinations and disease management, encouraging demand for faster and more accurate clinical decision-making. Greater emphasis on preventive animal healthcare and the humanization of pets is further supporting regular screening and diagnostic utilization.
Asia Pacific (Fastest-Growing Region)
In Asia Pacific, the companion animal diagnostics market is experiencing the fastest growth as pet ownership expands and veterinary healthcare becomes more sophisticated. Rising disposable incomes and changing attitudes toward companion animals are increasing willingness to spend on preventive and specialized care. Improvements in veterinary infrastructure, wider availability of diagnostic technologies, and growing awareness of early disease detection are helping broaden the use of diagnostic testing across both established and emerging markets.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants/Startups i Scale Low Medium High | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Laboratory Diagnostics ExpansionGermany strengthens the companion animal diagnostics market through increasing use of laboratory testing and precision veterinary diagnostics. Veterinary practices in Germany invest in reliable diagnostic workflows that support earlier disease identification and more targeted treatment planning.
France 🇫🇷
Preventive Pet Health FocusFrance supports the companion animal diagnostics market through increasing emphasis on preventive care and routine veterinary screening. Diagnostic providers in France develop accessible testing solutions that help veterinarians detect health conditions earlier and improve treatment outcomes.
Italy 🇮🇹
Clinic-Based Diagnostic ServicesItaly expands the companion animal diagnostics market through broader adoption of in-clinic diagnostic systems and routine wellness testing. Veterinary professionals in Italy prioritize efficient diagnostic capabilities that support timely treatment decisions while enhancing the overall standard of companion animal care.
Japan 🇯🇵
Advanced Companion CareJapan continues expanding companion animal diagnostics through increased demand for sophisticated veterinary services and routine health screening. Diagnostic providers in Japan focus on accurate testing platforms that support chronic disease management and personalized veterinary care.
South Korea 🇰🇷
Veterinary Technology UptakeSouth Korea advances the companion animal diagnostics market by integrating modern diagnostic technologies into veterinary clinics. Demand in South Korea supports rapid point-of-care testing and digital diagnostic tools that improve workflow efficiency and enhance pet healthcare services.
United States 🇺🇸
Preventive Veterinary TestingThe U.S. companion animal diagnostics market is shaped by growing emphasis on preventive veterinary care and advanced diagnostic services. Veterinary providers across the U.S. increasingly adopt rapid testing technologies and laboratory diagnostics to improve clinical decision-making and pet health management.
Segment Leadership and Growth Trends
Companion Animal Diagnostics Market Share (%), by Application, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportApplication Segment Analysis: Clinical Pathology (Largest & Fastest-Growing Segment)
Clinical pathology represented both the largest and fastest-growing application segment in the companion animal diagnostics market in 2026, accounting for 24.79% share. Its strong position reflects the central role of laboratory-based testing in identifying and monitoring common diseases and health conditions in companion animals. Increasing pet healthcare awareness, greater emphasis on preventive veterinary care, and rising demand for routine diagnostic screening are strengthening utilization of clinical pathology services. Veterinary professionals increasingly rely on laboratory findings to support timely diagnosis, treatment selection, and ongoing disease management, creating sustained demand for pathology-based diagnostic capabilities.
Technology Segment Analysis: Clinical Biochemistry (Largest Segment) vs Molecular Diagnostics (Fastest-Growing Segment)
Clinical biochemistry held the largest share of the technology segment in the companion animal diagnostics market in 2026, accounting for 24.79% share, driven by its broad applicability in assessing metabolic, organ, and general health conditions in companion animals. The routine nature of biochemical testing and its integration into veterinary health assessments support consistent utilization across clinical settings. Molecular diagnostics are expanding more rapidly as veterinarians increasingly seek sensitive and specific methods for identifying infectious diseases and other conditions at the molecular level. Advances in diagnostic precision and the growing importance of early disease detection are encouraging wider adoption of molecular techniques in companion animal healthcare.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application | Clinical Pathology, Bacteriology, Virology, Parasitology, Others | Clinical Pathology | Clinical Pathology |
| Technology | Clinical Biochemistry, Immunodiagnostics, Hematology, Molecular Diagnostics, Urinalysis, Others | Clinical Biochemistry | Molecular Diagnostics |
| Animal | Dogs, Cats, Horses, Others | Dogs | Cats |
| End Use | Diagnostic Laboratories, Veterinary Hospitals and Clinics, Point-Of-Care/In-House Testing, Research Institutes and Universities | Diagnostic Laboratories | Point-Of-Care/In-House Testing |
Competitive Landscape and Market Positioning
Major players in the companion animal diagnostics market:
1. IDEXX Laboratories Inc. (United States)
2. Zoetis Inc. (United States)
3. Thermo Fisher Scientific Inc. (United States)
4. Antech Diagnostics Inc. (United States)
5. FUJIFILM Corporation (Japan)
6. Virbac S.A. (France)
7. bioMérieux SA (France)
8. Neogen Corporation (United States)
9. Embark Veterinary Inc. (United States)
10. Esaote S.p.A. (Italy)
The companion animal diagnostics market is undergoing a profound transformation driven by the rapid integration of advanced screening technologies. Veterinary care is shifting toward automated, high-precision tools that allow for real-on-site testing and faster clinical decisions. This widespread upgrade in clinical capabilities is largely supported by specialized research alliances, which pull cutting-edge molecular techniques out of the lab and directly into regular veterinary clinics to meet the rising expectations of pet owners.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| IDEXX Laboratories Inc. (United States) | |||||||
| Zoetis Inc. (United States) | |||||||
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Antech Diagnostics Inc. (United States) | |||||||
| FUJIFILM Corporation (Japan) | |||||||
| Virbac S.A. (France) | |||||||
| bioMérieux SA (France) | |||||||
| Neogen Corporation (United States) | |||||||
| Embark Veterinary Inc. (United States) | |||||||
| Esaote S.p.A. (Italy). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Zoetis | Nov-25 | Zoetis acquired the Veterinary Pathology Group (VPG), a prominent diagnostic laboratory network operating across the UK and Ireland. This acquisition serves as a strategic milestone, granting Zoetis its first owned reference laboratories in the region and enhancing its ability to provide integrated diagnostic services, combining point-of-care solutions with sophisticated reference lab capabilities. |
| Zomedica | Sep-25 | Zomedica expanded its intellectual property portfolio through the issuance of four U.S. patents covering its TRUVIEW digital cytology and TRUFORMA diagnostic platforms. By strengthening its protections around automated slide processing and sensor technology, Zomedica bolsters its competitive positioning and long-term ability to capture market share within the rapidly scaling veterinary diagnostics sector. |
| Hill’s Pet Nutrition | May-25 | Hill’s Pet Nutrition formed a strategic partnership with MiDOG Animal Diagnostics to integrate advanced microbiome sequencing into veterinary care and nutrition research. The collaboration aims to leverage high-precision microbial diagnostics to guide targeted clinical treatments and develop personalized nutritional solutions, representing a shift toward data-driven, precision health management for companion animals. |
| IDEXX | Jan-25 | IDEXX introduced IDEXX Cancer Dx, a cost-effective, routine blood screening tool designed for the early detection of canine lymphoma. By simplifying access to oncological diagnostics, this launch targets a significant unmet need in general veterinary practice, enabling earlier intervention for at-risk patients and expanding the company's footprint in the growing veterinary oncology segment. |
| Antech Diagnostics | Jan-25 | Antech Diagnostics launched the truRapid FOUR lateral flow test, a comprehensive screening solution for common canine vector-borne diseases. This proprietary diagnostic platform enables rapid, multi-pathogen detection—including Anaplasma, Ehrlichia, Lyme, and heartworm—from a single sample, enhancing operational efficiency and diagnostic throughput at the point of care for veterinary practitioners. |
| Zoetis | Sep-24 | Zoetis launched the Vetscan OptiCell, a cartridge-based hematology analyzer utilizing AI-powered technology to deliver point-of-care Complete Blood Count (CBC) analysis. The system provides lab-quality diagnostic results with increased speed and reduced spatial requirements, supporting a trend toward greater clinical decentralization and enhancing the efficiency of diagnostic workflows in busy veterinary settings. |
| Oxford BioDynamics | Jun-24 | Oxford BioDynamics developed the EpiSwitch SCB test, a non-invasive blood-based diagnostic capable of distinguishing between six common canine cancers with high accuracy. This technology offers a novel alternative to more invasive biopsy procedures, providing veterinarians with a clinically significant tool to improve the early detection and management of complex malignancies in canine patients. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Companion Animal Diagnostics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Sample Type | Blood, Urine, Feces, Saliva & Oral Samples, Tissue & Other Specimens |
| Test Format | Laboratory-Based Testing, Point-of-Care Testing, At-Home Testing |
| Distribution Channel | Direct Sales, Veterinary Distributors, Online & E-Commerce Channels, Retail & Pharmacy Channels |
Companion Animal Diagnostics Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Veterinary Clinic Diagnostic Workflow Assessment |
|
| Pet Insurance Impact on Diagnostic Testing Demand |
|
| Preventive Care and Wellness Testing Opportunity Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow large is the companion animal diagnostics market?
What is the expected industry size of companion animal diagnostics by 2036?
How are changing pet ownership behaviors influencing diagnostic adoption in the companion animal diagnostics market?
What role are point-of-care and AI technologies playing in the companion animal diagnostics market?
Why does Clinical Biochemistry hold the largest share of the companion animal diagnostics market?
What is driving the rapid growth of Molecular Diagnostics in the companion animal diagnostics market?
Why does North America dominate the companion animal diagnostics market?
What factors are driving Asia Pacific’s rapid growth in companion animal diagnostics?
Who holds a significant market share in the companion animal diagnostics landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization